Dataset:
The use and impact of bevacizumab (Avastin) for the treatment of metastatic colorectal cancer treatment in Australia
The use and impact of bevacizumab (Avastin) for the treatment of metastatic colorectal cancer treatment in Australia
| dc.coverage.spatial | Australia | en_US |
| dc.date.accessioned | 2021-11-26T10:33:40Z | |
| dc.date.available | 2021-11-26T10:33:40Z | |
| dc.date.issued | 2011 | en_US |
| dc.description.abstract | This project was established to conduct a long-term evaluation of the way in which bevacizumab (Avastin) is used to treat metastatic colorectal cancer in the real world clinical setting. Bevacizumab became available under the Pharmaceutical Benefits Scheme (PBS) in July 2009. This study has access to the PBS history of all patients prescribed bevacizumab since its PBS-subsidy and has approval for annual data updates until 2016. Originating source(s): Medicare Australia [Pharmaceutical Benefits Scheme] [Patient/Medicare enrolment data] | en_US |
| dc.identifier.uri | http://hdl.handle.net/1959.4/004_279 | |
| dc.language | English | |
| dc.language.iso | EN | en_US |
| dc.rights | CC-BY-NC-ND | en_US |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/ | en_US |
| dc.subject.other | Pharmacoepidemiology | en_US |
| dc.subject.other | Drug treatments | en_US |
| dc.subject.other | Patterns of cancer care | en_US |
| dc.title | The use and impact of bevacizumab (Avastin) for the treatment of metastatic colorectal cancer treatment in Australia | en_US |
| dc.type | Dataset | en_US |
| dcterms.accessRights | metadata only access | |
| dcterms.rights | Access to the data is subject to originating data custodian approval. Ethics committee approval and other access conditions apply. | en_US |
| dcterms.rightsHolder | University of New South Wales | en_US |
| dspace.entity.type | Dataset | en_US |
| unsw.accessRights.uri | http://purl.org/coar/access_right/c_14cb | |
| unsw.contributor.corporate | Adult Cancer Program, Lowy Cancer Research Centre | en_US |
| unsw.contributor.leadChiefInvestigator | Caruso, Lena | en_US |
| unsw.contributor.researchDataCreator | Caruso, Lena | en_US |
| unsw.description.contact | Access type: Access by request. Contact the Information Officer for more information: info.acp@unsw.edu.au. | en_US |
| unsw.description.storageplace | Adult Cancer Program, Lowy Cancer Research Centre, Faculty of Medicine, UNSW Australia | en_US |
| unsw.identifier.doi | https://doi.org/10.26190/unsworks/1379 | |
| unsw.relation.OriginalPublicationAffiliation | Adult Cancer Program, Lowy Cancer Research Centre, , Adult Cancer Program, Lowy Cancer Research Centre, | en_US |
| unsw.relation.OriginalPublicationAffiliation | Caruso, Lena, PVC (Research Training), DVC (Research), | en_US |
| unsw.relation.faculty | Other UNSW | |
| unsw.relation.projectDesc | This project was established to conduct a long-term evaluation of the way in which bevacizumab (Avastin) is used to treat metastatic colorectal cancer in the real world clinical setting. Bevacizumab became available under the Pharmaceutical Benefits Scheme (PBS) in July 2009. This study has access to the PBS history of all patients prescribed bevacizumab since its PBS-subsidy and has approval for annual data updates until 2016. | en_US |
| unsw.relation.projectTitle | Use of bevacizumab in Australia | en_US |
| unsw.subject.fieldofresearchcode | 111299 Oncology and Carcinogenesis not elsewhere classified | en_US |
| unsw.subject.fieldofresearchcode | 111502 Clinical Pharmacology and Therapeutics | en_US |
| unsw.subject.fieldofresearchcode | 111799 Public Health and Health Services not elsewhere classified | en_US |